| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |